AHR Stock Analysis: Buy, Sell, or Hold?
AHR - American Healthcare REIT, Inc.
$55.93
0.16 (0.29%)
▲
5d:
+2.98%
30d:
-0.8%
90d:
+11.57%
BUY
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When AHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AHR shows positive signals but monitor for confirmation. Market pricing in 2.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: AHR shows positive signals but monitor for confirmation. Market pricing in 2.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$48.20
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$29.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHR is currently trading at $55.93, which is considered fair relative to its 30-day fair value range of $54.17 to $56.99. The stock's valuation (Forward PE: 56.5) is in line with its historical norms (60.7). Remarkably, the market is currently pricing in an annual earnings decline of 2.4% over the next few years. This pessimistic expectation contrasts with the company's recent 157.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $56.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AHR scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $63.67 (+13.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $56.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AHR scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $63.67 (+13.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$54.17 -
$56.99
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($63.67)
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$54.17 -
$56.99
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$52.33
Resistance Level
$56.70
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
56.49
Wall Street Target
$63.67
(+13.8%)
Revenue Growth (YoY)
24.7%
Earnings Growth (YoY)
157.5%
Profit Margin
4.8%
Valuation Discount vs History
-2.4% cheaper
PE vs Historical
56.5 vs 60.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.4%
(market-implied from PE analysis)
1-Year Target
$54.59
(-2%)
2-Year Target
$53.28
(-5%)
3-Year Target
$52.00
(-7%)
3-Yr Target (if PE normalizes)
(PE: 56→61)
$55.87
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 56.5, Growth: 66.2%)
$188.76
(+238%)
Base:
(SPY PE: 20.1, Growth: 66.2%)
$67.06
(+20%)
Bear:
(PE: 17.1, Growth: 66.2%)
$57.00
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (82x PE), but valuation improves significantly next year (56x PE) as earnings recover.
Trailing PE: 82.01 | Current EPS (TTM): $0.68
Bull Case
$89.31
(+60%)
Analyst growth 45.6%, PE expands to 90.2
Base Case
$81.19
(+45%)
Market implied 45.6%, PE stable at 82.0
Bear Case
$37.92
(-32%)
Severe decline -20.0%, PE contracts to 69.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 56.5 to 60.7
Stabilization Target:
$60.09
(+7.4%)
PE Expansion Potential:
+7.4%
Share & Embed Analysis
Last updated: August 23, 2026 8:00 AM ET
Data refreshes hourly during market hours. Next update: 9:00 AM
Data refreshes hourly during market hours. Next update: 9:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark E Foster
SELL
2000 shares
2026-03-25
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$100 | 66 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$256 | 63 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$23 | 53 HOLD |
|
OHI
Omega Healthcare Investo… |
HOLD
16 analysts |
$52 | 77 BUY |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$16 | 64 BUY |
